R. Vriesendorp

739 total citations
15 papers, 570 citations indexed

About

R. Vriesendorp is a scholar working on Reproductive Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, R. Vriesendorp has authored 15 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Reproductive Medicine, 4 papers in Nephrology and 3 papers in Molecular Biology. Recurrent topics in R. Vriesendorp's work include Ovarian cancer diagnosis and treatment (5 papers), Renal Diseases and Glomerulopathies (3 papers) and Testicular diseases and treatments (2 papers). R. Vriesendorp is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Renal Diseases and Glomerulopathies (3 papers) and Testicular diseases and treatments (2 papers). R. Vriesendorp collaborates with scholars based in Netherlands, United States and Pakistan. R. Vriesendorp's co-authors include Dick de Zeeuw, Herbert M. Pinedo, Paul E. de Jong, W W ten Bokkel Huinink, M. van Lent, Hans C. van Houwelingen, C. Kooyman, A.C.M. van Lindert, J.P. Neijt and A.T. van Oosterom and has published in prestigious journals such as The Lancet, Cancer and The American Journal of Medicine.

In The Last Decade

R. Vriesendorp

15 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Vriesendorp Netherlands 11 203 184 121 86 84 15 570
Salim Başol Tekin Türkiye 14 16 0.1× 114 0.6× 131 1.1× 16 0.2× 297 3.5× 50 627
Michael M. Braun United States 9 77 0.4× 109 0.6× 143 1.2× 42 0.5× 68 0.8× 19 566
F. Innocenti Italy 10 34 0.2× 61 0.3× 367 3.0× 42 0.5× 211 2.5× 25 676
Cemil Ekinci Türkiye 11 28 0.1× 111 0.6× 92 0.8× 11 0.1× 92 1.1× 26 373
Kentarou Kudou Japan 15 232 1.1× 587 3.2× 255 2.1× 14 0.2× 54 0.6× 32 1.0k
Morag Chisholm United Kingdom 15 4 0.0× 149 0.8× 104 0.9× 19 0.2× 53 0.6× 37 604
Asterios Karagiannis Greece 9 47 0.2× 141 0.8× 28 0.2× 74 0.9× 29 0.3× 20 442
Eleftheria Kalogera United States 18 240 1.2× 1.1k 6.0× 106 0.9× 5 0.1× 282 3.4× 34 1.7k
Jialiang Gan China 15 11 0.1× 119 0.6× 107 0.9× 8 0.1× 315 3.8× 44 659
L Wahlqvist Sweden 17 81 0.4× 554 3.0× 344 2.8× 14 0.2× 97 1.2× 34 903

Countries citing papers authored by R. Vriesendorp

Since Specialization
Citations

This map shows the geographic impact of R. Vriesendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Vriesendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Vriesendorp more than expected).

Fields of papers citing papers by R. Vriesendorp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Vriesendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Vriesendorp. The network helps show where R. Vriesendorp may publish in the future.

Co-authorship network of co-authors of R. Vriesendorp

This figure shows the co-authorship network connecting the top 25 collaborators of R. Vriesendorp. A scholar is included among the top collaborators of R. Vriesendorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Vriesendorp. R. Vriesendorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hofstede, Hadewych J. M. ter, Peter P. Koopmans, David M. Burger, et al.. (2012). Lopinavir Plasma Concentrations and Serum Lipids in Therapy Naïve HIV-Patients: A Sub Analysis of the FREE Study. Pharmacology & Pharmacy. 3(1). 90–96. 1 indexed citations
2.
Wiggenraad, Ruud, A. Goossens, Rhonda M. Brand, et al.. (2007). Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clinical Otolaryngology. 32(5). 384–390. 101 indexed citations
3.
Vriesendorp, R., et al.. (1992). Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.. PubMed. 7 Suppl 1. 91–6. 22 indexed citations
4.
Jong, Paul E. de, et al.. (1990). Additive Antiproteinuric Effect of the NSAID Indomethacin and the ACE Inhibitor Lisinopril. American Journal of Nephrology. 10(1). 94–97. 33 indexed citations
5.
Huinink, W W ten Bokkel, R. Vriesendorp, A.T. van Oosterom, et al.. (1987). Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands joint study group for ovarian cancer. European Journal of Cancer and Clinical Oncology. 23(7). 997–998. 2 indexed citations
6.
Vriesendorp, R., et al.. (1987). Prediction of normal tissue damage induced by cancer chemotherapy. Cancer Chemotherapy and Pharmacology. 19(4). 273–6. 13 indexed citations
7.
Vriesendorp, R., et al.. (1986). Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.. PubMed. 25(2). 105–10. 33 indexed citations
8.
Kalken, C.K. van, Jan van der Meulen, P. L. Oe, R. Vriesendorp, & A. J. M. Donker. (1986). Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension. European Journal of Clinical Pharmacology. 31(1). 63–68. 2 indexed citations
9.
Vriesendorp, R., A. J. M. Donker, Dick de Zeeuw, et al.. (1986). Effects of nonsteroidal anti-inflammatory drugs on proteinuria. The American Journal of Medicine. 81(2). 84–94. 53 indexed citations
10.
Vriesendorp, R., A. J. M. Donker, Dick de Zeeuw, Paul E. de Jong, & G. K. van der Hem. (1985). Antiproteinuric Effect of Naproxen and Indomethacin. American Journal of Nephrology. 5(4). 236–242. 26 indexed citations
11.
Vriesendorp, R., J.G. Aalders, D.Th. Sleijfer, et al.. (1984). Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).. PubMed. 68(5). 779–81. 17 indexed citations
12.
Stoter, G., C. P. J. Vendrik, A Struyvenberg, et al.. (1984). Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin. Cancer. 54(8). 1521–1524. 36 indexed citations
13.
Neijt, J.P., M.E.L. van der Burg, R. Vriesendorp, et al.. (1984). RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA. The Lancet. 324(8403). 594–600. 207 indexed citations
14.
Vriesendorp, R., J.G. Aalders, D.Th. Sleijfer, et al.. (1984). Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer. Gynecologic Oncology. 17(3). 271–276. 22 indexed citations
15.
Mulder, NH, et al.. (1984). Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).. PubMed. 27(10). 389–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026